Your browser doesn't support javascript.
loading
Parathyroid Hormone Related Peptide Hypercalcemia as a Presentation of Endometrial Clear Cell Carcinoma.
Georges, Claudia; Adhikari, Biplov; Koundaveety, Soumya; Jones, Robert; Paudel, Kalyan; Haas, Christopher.
Afiliación
  • Georges C; Department of Medicine, MedStar Health Internal Medicine Residency Program, MedStar Union Memorial Hospital, Baltimore, MD, USA.
  • Adhikari B; Department of Medicine, MedStar Health Internal Medicine Residency Program, MedStar Union Memorial Hospital, Baltimore, MD, USA.
  • Koundaveety S; Department of Medicine, MedStar Health Internal Medicine Residency Program, MedStar Union Memorial Hospital, Baltimore, MD, USA.
  • Jones R; Department of Pathology, MedStar Franklin Square Medical Center, Baltimore, MD, USA.
  • Paudel K; Department of Radiology, MedStar Harbor Hospital, Baltimore, MD, USA.
  • Haas C; Department of Internal Medicine, MedStar Franklin Square Medical Center, Baltimore, MD, USA.
Article en En | MEDLINE | ID: mdl-38596557
ABSTRACT
Hypercalcemia is a frequent complication of solid tumors and hematologic malignancies yet is only rarely associated with endometrial clear cell carcinoma. Here we report on a 70-year-old female who presented in the context of hip fracture and was incidentally found to have humoral hypercalcemia of malignancy secondary to endometrial clear cell carcinoma. This rare association makes endometrial cancer one of the differential diagnoses to be considered when assessing incidentally found symptomatic or asymptomatic hypercalcemia in the appropriate patient population.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Community Hosp Intern Med Perspect Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Community Hosp Intern Med Perspect Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos